BUSINESS SEGMENT INFORMATION (Tables)

12 Months Ended

Sep. 30, 2022

BUSINESS SEGMENT INFORMATION [Abstract]

Segment Reporting Information by Segment

The following tables presents selected financial information about the Company’s reportable segments and Corporate for the purpose of reconciling to the consolidated totals for the fiscal years ended September 30, 2022 and 2021:

For the year ended September 30, 2022 (in thousands)	Consolidated		Logistics		Life Sciences		Manufacturing		Corporate
Revenues	$	316,863	$	295,343	$	11,625	$	9,895	$	—
Forwarding expenses and cost of revenues		250,666		242,946		2,933		4,787		—
Gross profit		66,197		52,397		8,692		5,108		—
Selling, general and administrative		54,723		40,075		5,421		3,095		6,132
Amortization of intangible assets		1,976		—		—		—		1,976
Income (loss) from operations		9,498		12,322		3,271		2,013		(8,108	)
Interest expense		1,276		988		123		146		19
Identifiable assets		126,532		64,630		10,884		4,324		46,694
Capital expenditures, net of disposals	$	551	$	300	$	198	$	53	$	—

For the year ended September 30, 2021 (in thousands)	Consolidated		Logistics		Life Sciences		Manufacturing		Corporate
Revenues	$	146,419	$	125,863	$	11,992	$	8,564	$	—
Forwarding expenses and cost of revenues		113,986		106,139		3,864		3,983		—
Gross profit		32,433		19,724		8,128		4,581		—
Selling, general and administrative		27,362		16,656		4,469		2,696		3,541
Amortization of intangible assets		1,120		—		—		—		1,120
Income (loss) from operations		3,951		3,068		3,659		1,885		(4,661	)
Interest expense		589		294		117		156		22
Identifiable assets		115,924		59,026		9,344		3,905		43,649
Capital expenditures, net of disposals	$	234	$	20	$	174	$	40	$	—